Search

Search Constraints

You searched for: Author/Creator Kawakami, Hisato

Search Results

1. 330. RANDOMIZED PHASE II STUDY OF DOCETAXEL VERSUS PACLITAXEL IN PATIENTS WITH ESOPHAGEAL SCC REFRACTORY TO FLUOROPYRIMIDINE- AND PLATINUM-BASED CHEMOTHERAPY: OGSG1201. (24th September 2022)

2. [fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification. Issue 12 (24th May 2019)

3. A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1‐3 M0 Gastric Cancer (OGSG 1601). (30th September 2019)

4. Clinical and immune profiling for cancer of unknown primary site. Issue 1 (13th September 2019)

5. Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors. (6th January 2021)

6. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. (12th December 2020)

7. Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108). Issue 6 (16th July 2021)

8. FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer. Issue 1 (20th November 2020)

9. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb‐202 in gastric cancer. Issue 6 (1st June 2021)

10. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. (27th October 2013)